The Frida Blog

Plain-language, educational articles on schizophrenia, psychosis, antipsychotic medications, and lived experience — by ColdAI.

940 articles, updated weekly

Browse by topic

Schizophrenia Overview(122) Psychosis & Episodes(76) Medications(143) Side Effects(32) Famous People with Schizophrenia(35) Patient Experiences(120) CBT for Psychosis(65) Hospitalisation & Crisis(53) Lifestyle & Wellbeing(226) For Families & Caregivers(50) Engineering(17) Schizophrenia Research(1)

Latest articles

Fertility on antipsychotics: prolactin and beyond

Antipsychotics can affect fertility — most often through prolactin. Most fertility issues are reversible with the right medication adjustment and time.

Moving to a rural town for the quiet

I left Brooklyn for a town of 1,800 people in upstate New York. The quiet was the medicine. Access to care was the cost.

Schizophrenia in Jewish communities

Jewish communities range from secular to ultra-Orthodox and bring distinct strengths and challenges to schizophrenia care. This is a guide to resources, ritual considerations, and where to find help.

Supported education programs

Schizophrenia frequently emerges during the college years. Supported education programs are designed to help young people stay in school — or return to it — when symptoms have interrupted study.

Applying for SSDI with schizophrenia: a step-by-step guide

SSDI is a federal disability program for workers who have paid into Social Security. Schizophrenia is one of the conditions for which SSA has a clear listing — here is how to apply.

Hypersomnia from antipsychotics: when sleep becomes too much

Many people on antipsychotics struggle with the opposite of insomnia — sleeping 12 hours and still being tired. Hypersomnia has causes worth understanding and options worth trying.

Supported employment (IPS): the evidence-based model that works

Individual Placement and Support — IPS — is the most studied employment intervention in serious mental illness. Across more than 25 randomised trials, it consistently doubles competitive employment rates.

Olanzapine pamoate (Zyprexa Relprevv) and post-injection syndrome

Zyprexa Relprevv is the long-acting injectable form of olanzapine — and the only LAI that requires three hours of in-clinic observation after every injection. Here's why.

Quetiapine vs olanzapine: sedation, weight, and when each is chosen

Quetiapine and olanzapine are two of the most-prescribed atypicals — both sedating, both metabolically heavy, but with different efficacy and very different roles in practice.

The McGorry omega-3 prevention trial: what happened next

A 2010 fish-oil trial suggested omega-3s could prevent psychosis in at-risk young people. A larger replication failed. Here is what the science actually shows now.

Schizophrenia and PTSD: shared symptoms, separate diagnoses

Trauma is common in people with schizophrenia, and PTSD symptoms can mimic — or amplify — psychotic ones. The two conditions need to be addressed together.

Antipsychotics in older adults: dose, monitoring, and the FDA box warning

Antipsychotics in older adults work — but dosing, monitoring, and indication all have to change. The Beers Criteria and FDA boxed warning shape every prescribing decision.

Myth: People with schizophrenia shouldn't have children

The blanket idea that people with schizophrenia shouldn't have children carries echoes of eugenics and is not supported by modern evidence on parenting or genetics.

Schizophrenia care in Pennsylvania: HealthChoices, OMHSAS

Pennsylvania uses HealthChoices behavioural-health Medicaid managed care alongside a county-administered system overseen by OMHSAS. This guide walks through the structure and the 302 commitment process.

Tai chi for schizophrenia: a gentler movement option

Tai chi is gentle, low-impact, and accessible to people with limited fitness. A growing body of trials suggests it can help with negative symptoms, balance, and stress in schizophrenia.

Asian American communities, schizophrenia, and family stigma

Asian American adults use mental health services at the lowest rate of any major US racial group. The gap is not about lower need — it is about stigma, family expectation, and a workforce that rarely matches the patient.

Vaping and schizophrenia: harm reduction or new problem?

Vaping looks safer than smoking on most measures but is not without its own risks. For people with schizophrenia, the answer depends on whether vaping is replacing cigarettes or adding to them.

Medicaid for schizophrenia: how state programs differ

Medicaid is the single largest funder of schizophrenia care in the United States — but every state runs its own program with different rules. Here's how to navigate yours.

Impulsivity in schizophrenia: medication, harm reduction

Impulsivity in schizophrenia has many sources — symptoms, medication side effects, sleep loss, substances. Knowing which one is driving today's behaviour changes the response.

Schizophrenia care in Australia: headspace, EPPIC, and Medicare

Australia pioneered early intervention in psychosis through EPPIC, built the world's largest youth mental health network in headspace, and funds psychology through Medicare. Here's how the system fits together.

SSRIs and antipsychotics: common combinations, common pitfalls

Combining SSRIs with antipsychotics is one of the most common decisions in modern schizophrenia care. The decision is rarely binary — it's about which SSRI, at what dose, with what monitoring.

Tactile hallucinations: feeling things that aren't there

Tactile hallucinations are touch sensations with no external source — from feather-light brushes to the unforgettable sensation of insects crawling under the skin.

Religious delusions: distinguishing faith from delusion

Religious delusions sit on the most sensitive boundary in psychiatry — the line between sincere faith and a belief that has become symptomatic. Both deserve respect.

Coping cards for schizophrenia: how to make them, how to use them

When you are distressed, you cannot remember everything you know. Coping cards put your best advice to yourself in your pocket — short, clear, and ready when you need them.

Coming back from rock bottom: my year on the streets

I spent fourteen months sleeping outside in Phoenix during an untreated psychotic episode. This is what got me back inside, and what it took to stay.

Accepting disability: my journey to applying for SSDI

I am 38 and I spent ten years refusing to apply for disability. This is the story of why I finally did, what the process actually looked like, and how it changed my life.

How I told my employer about my schizophrenia

I spent three years at my company before telling anyone. When I finally did — partly out of necessity, partly out of exhaustion — almost nothing about my job changed. Here is what the conversation actually looked like.

Living with schizoaffective disorder (a composite story)

It took three psychiatrists and seven years for someone to use the right word for what was happening to me. This is a composite story of life with schizoaffective disorder.

When to call 911 (and when not to) for a mental health crisis

Calling 911 during a psychiatric crisis can save a life — and can also lead to outcomes that make things worse. Here is how to think clearly about which option to use.

Homelessness and schizophrenia: causes, consequences, and what works

People with schizophrenia are dramatically over-represented among the homeless. The path out is not mysterious — but it requires committed housing, not just shelters.